Inhibition of gastric inhibitory polypeptide signaling prevents obesity

K Miyawaki, Y Yamada, N Ban, Y Ihara, K Tsukiyama… - Nature medicine, 2002 - nature.com
K Miyawaki, Y Yamada, N Ban, Y Ihara, K Tsukiyama, H Zhou, S Fujimoto, A Oku, K Tsuda…
Nature medicine, 2002nature.com
Secretion of gastric inhibitory polypeptide (GIP), a duodenal hormone, is primarily induced
by absorption of ingested fat. Here we describe a novel pathway of obesity promotion via
GIP. Wild-type mice fed a high-fat diet exhibited both hypersecretion of GIP and extreme
visceral and subcutaneous fat deposition with insulin resistance. In contrast, mice lacking
the GIP receptor (Gipr−/−) fed a high-fat diet were clearly protected from both the obesity and
the insulin resistance. Moreover, double-homozygous mice (Gipr−/−, Lep ob/Lep ob) …
Abstract
Secretion of gastric inhibitory polypeptide (GIP), a duodenal hormone, is primarily induced by absorption of ingested fat. Here we describe a novel pathway of obesity promotion via GIP. Wild-type mice fed a high-fat diet exhibited both hypersecretion of GIP and extreme visceral and subcutaneous fat deposition with insulin resistance. In contrast, mice lacking the GIP receptor (Gipr−/−) fed a high-fat diet were clearly protected from both the obesity and the insulin resistance. Moreover, double-homozygous mice (Gipr−/−, Lepob/Lepob) generated by crossbreeding Gipr−/− and obese ob/ob (Lepob/Lepob) mice gained less weight and had lower adiposity than Lepob/Lepob mice. The Gipr−/− mice had a lower respiratory quotient and used fat as the preferred energy substrate, and were thus resistant to obesity. Therefore, GIP directly links overnutrition to obesity and it is a potential target for anti-obesity drugs.
nature.com